ATLAS Biolabs Participates in Two European Research Projects
News Oct 11, 2012
ATLAS Biolabs has announced its participation in two European research projects focusing on the impact of chromatin dynamics on DNA damage (aDDRess) and the influence of DNA damage on cellular aging (CodeAge).
ATLAS Biolabs will be responsible for the analysis of the NGS data collected in both projects.
This task also includes the development of new strategies and bioinformatics tools for NGS data analysis and the identification of biomarkers of DNA damage.
The DNA in the nuclei of eukaryotic cells is tightly wrapped around histones to form chromatin, a structure subject to constant dynamic changes in the course of DNA replication and DNA repair.
In particular, a better understanding of chromatin dynamics in DNA repair would provide novel insights into the mechanisms by which the cell protects itself from DNA damage and the disturbances that cause human disease.
Moreover, by investigating the cellular responses triggered by DNA damage, it would be possible to find new approaches for preventive therapies and elucidate the process of aging.
Both the aDDRess and CodeAge projects receive funding from the FP7 Marie Curie Initial Training Network of the European Union.
The Training Network opens up career opportunities for young talents and aims to accelerate the transfer of research findings into medical applications by encouraging research collaborations between academic institutions and medium-sized commercial enterprises.
The two projects involve a total of 22 research groups in 9 different European countries.
“aDDRess and CodeAge will combine state-of-the-art knowledge in basic molecular genetics, omics technologies, translational research and clinical application. We are excited about contributing to the analysis of NGS data within both projects,” said Professor Peter Nürnberg, CEO of ATLAS Biolabs GmbH.
Professor Nürnberg continued, “I am convinced that our customers will benefit from the added competencies that we will gather from this program.”
The European research projects aDDRess and CodeAge
aDDRess (chromatin dynamics on the DNA damage response) and CodeAge (Chronic DNA damage in Ageing) are being funded for four years by the Marie Curie Initial Training Networks within the European FP7 program.
The Marie Curie Initial Training Networks are open to young researchers who want to gain experience abroad in the private sector, and to complete their training by participating in a joint European research project.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018